STUDY OF BINDING ABILITY OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES WITH PROTEIN

硫代磷酸寡核苷酸与蛋白质结合能力的研究

基本信息

  • 批准号:
    08670540
  • 负责人:
  • 金额:
    $ 1.6万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

We've recognized that phosphorothioate oligonucleotides (S-ODN) showed potent anti-herpetic activities when target site was limited near the splicing site. It was implied that S-ODN interfered the conservative structure which could be essential for the splicing, thus showed potent anti-herpetic activities. This was one explanation why S-ODN targeted splicing site showed potent anti-herpetic activities. However, it has been reported that G rich sequences reveal sequence non-specific biological activities. S-ODN may reveal another mechanism which might be based on strong protein binding activities. S-ODN strongly bound to serum protein at the ratio of 86.6%, while 21.6% for phosphodiester oligonucleotides (D-ODN). Binding activities which directly bound to the virus was more than 50% for S-ODN, on the other hand it was less than 5% for D-ODN.Thirteen mer S-ODN showed inhibitory effect on virus entry into the cell at the early stage of infection, while D-ODN did not. CD spectrum of S-ODN implied G-quartet structure, however, the relation between biological activities and higher dimension structure could not be clear.Moreover, we tried to enhance the anti-herpetic activities of S-ODN by using cationic liposomes. Cationic liposomes is useful tool to enhance the anti-herpetic activities of D-ODN, while it was not the case for SOD.One of the reason might be strong protein binding activities of S-ODN.From this study, the caution is proposed when S-ODN containing G-rich sequences might involve another mechanism other than antisense manner. We should carefully select the drug delivery system to enhance the biological activities of S-ODN.
硫代磷酸寡核苷酸(S-ODN)在靶位点限制在剪接位点附近时显示出较强的抗疱疹活性。这表明S-ODN干扰了剪切所必需的保守结构,从而表现出较强的抗疱疹活性。这也解释了S-ODN靶向剪接位点的抗疱疹病毒活性。然而,据报道,富含G的序列揭示序列非特异性生物活性。S-ODN可能揭示了另一种机制,该机制可能基于强蛋白结合活性。S-ODN与血清蛋白的结合率为86.6%,而与磷酸二酯寡核苷酸(D-ODN)的结合率为21.6%。S-ODN与病毒的结合活性大于50%,而D-ODN与病毒的结合活性小于5%,S-ODN在感染早期对病毒进入细胞有抑制作用,而D-ODN对病毒进入细胞无抑制作用。S-ODN的CD谱显示其具有G-四联体结构,但其生物活性与高维结构的关系尚不清楚。阳离子脂质体能增强D-ODN的抗疱疹活性,而SOD则不能,其原因之一可能是S-ODN具有较强的蛋白结合活性,因此,当S-ODN含有富含G的序列时,应注意其可能涉及的机制可能不是反义方式。因此,应谨慎选择给药系统,以提高S-ODN的生物活性。

项目成果

期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
東海林洋子、他: "遺伝子医薬品の研究動向" 日本臨床. 56(8). 238-247 (1998)
Yoko Tokairin 等人:“遗传医学研究趋势”,日本临床杂志 56(8) (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
東海林洋子: "遺伝子医薬品のドラッグデリバリーシステム" Antisense. 1(2). 50-56 (1998)
Yoko Tokairin:“基因药物的药物输送系统”反义 1(2)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shoji Y.,et al.: "Cellular uptake and biological effects of antisense ologodeoxynucleotides analogs targeted to herpes simplex virus." Antimicrob. Agents Chem.40. 1670-1675 (1996)
Shoji Y.等人:“针对单纯疱疹病毒的反义寡脱氧核苷酸类似物的细胞摄取和生物效应。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
東海林洋子、他: "アンチセンスオリゴヌクレオチドの家兎ヘルペス角膜炎に対する効果の基礎的検討。" Jpn Clin Pharmacol Ther. 27. 309-310 (1996)
Yoko Tokairin 等人:“反义寡核苷酸对家兔疱疹性角膜炎影响的基础研究”Jpn Clin Pharmacol Ther 27. 309-310 (1996)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shoji Y., et al.: "Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol." J.Drug Targeting. 5(4). 261-273 (1998)
Shoji Y. 等人:“用香叶醇修饰的反义硫代磷酸寡核苷酸 5 端增强抗疱疹活性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHOJI Yoko其他文献

SHOJI Yoko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHOJI Yoko', 18)}}的其他基金

The Interdisciplinary Research Into Independents and Social Work
独立人士与社会工作的跨学科研究
  • 批准号:
    21330142
  • 财政年份:
    2009
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A Comprehensive Research on the Stand and Function of Social Welfare Institutions in the Community
社会福利机构在社区的地位和作用综合研究
  • 批准号:
    61301025
  • 财政年份:
    1986
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Co-operative Research (A)

相似海外基金

Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10806783
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10689248
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
  • 批准号:
    10501862
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Micrococcal nuclease-triggered antibiotics release: a prophylactic implant coating against S. aureus infections
微球菌核酸酶触发的抗生素释放:针对金黄色葡萄球菌感染的预防性植入物涂层
  • 批准号:
    10684948
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
Micrococcal nuclease-triggered antibiotics release: a prophylactic implant coating against S. aureus infections
微球菌核酸酶触发的抗生素释放:针对金黄色葡萄球菌感染的预防性植入物涂层
  • 批准号:
    10239251
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
Micrococcal nuclease-triggered antibiotics release: a prophylactic implant coating against S. aureus infections
微球菌核酸酶触发的抗生素释放:针对金黄色葡萄球菌感染的预防性植入物涂层
  • 批准号:
    10463666
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
Defining TLR9 regulatory sequences in natural DNA; implication for vaccine develo
定义天然 DNA 中的 TLR9 调控序列;
  • 批准号:
    7712519
  • 财政年份:
    2009
  • 资助金额:
    $ 1.6万
  • 项目类别:
Defining TLR9 regulatory sequences in natural DNA; implication for vaccine develo
定义天然 DNA 中的 TLR9 调控序列;
  • 批准号:
    7867927
  • 财政年份:
    2009
  • 资助金额:
    $ 1.6万
  • 项目类别:
Development of Ets2-Inhibitors
Ets2抑制剂的开发
  • 批准号:
    7847347
  • 财政年份:
    2009
  • 资助金额:
    $ 1.6万
  • 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
  • 批准号:
    7939375
  • 财政年份:
    2009
  • 资助金额:
    $ 1.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了